This Ollie's Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Piper Sandler analyst David Amsellem downgraded Amphastar Pharmaceuticals, Inc. AMPH from Overweight to Neutral and lowered the price target from $66 to $36. Amphastar Pharma shares closed at $33.39 on Monday. See how other analysts view this stock.
  • Baird analyst Peter Arment downgraded Triumph Group, Inc. TGI from Outperform to Neutral but raised the price target from $20 to $26. Triumph Group shares closed at $25.10 on Monday. See how other analysts view this stock.
  • Jefferies analyst Randal Konik downgraded the rating for Ollie’s Bargain Outlet Holdings, Inc. OLLI from Buy to Hold and lowered the price target from $125 to $111. Ollie’s Bargain shares closed at $107.63 on Monday. See how other analysts view this stock.
  • UBS analyst Manav Gupta downgraded Calumet, Inc. CLMT from Neutral to Sell and cut the price target from $20.5 to $15. Calumet shares closed at $18.34 on Monday. See how other analysts view this stock.
  • Wolfe Research analyst Trevor Allinson downgraded the rating for American Woodmark Corporation AMWD from Outperform to Peer Perform. American Woodmark shares closed at $75.65 on Monday. See how other analysts view this stock.

Considering buying OLLI stock? Here’s what analysts think:

AMPH Logo
AMPHAmphastar Pharmaceuticals Inc
$23.02-3.07%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
16.43
Growth
72.52
Quality
50.96
Value
53.93
Price Trend
Short
Medium
Long
Got Questions? Ask
How will Amphastar Pharmaceuticals rebound?
What factors influenced Triumph Group's downgrade?
Is there a buying opportunity in Ollie's Bargain Outlet now?
Which investors are shifting focus from Calumet?
Could American Woodmark attract new buyers after downgrade?
What impact will downgrades have on small-cap stocks?
Which sectors are most vulnerable to analyst downgrades?
How might investor sentiment change for downgraded stocks?
What are the long-term implications for pharmaceutical companies?
Which investment strategies work best post-downgrade?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: